Abstract
Introduction
This real-world, retrospective review of SLT outcomes at Lancashire Teaching Hospitals NHS Foundation Trust aimed to establish whether there is any net benefit in using topical drop treatment prior to SLT compared with proceeding directly to SLT as a first-line treatment. Several studies have shown that SLT gives the greatest reduction in intraocular pressure (IOP) for eyes that have not received prior treatment with drops. Here, we look at different topical therapies used prior to SLT and investigate SLT efficacy following these.
Method
Data were collected from 196 SLT naïve eyes with ocular hypertension or primary open-angle glaucoma who underwent SLT between January 2022 and May 2022. The eyes had received either no prior topical therapy or one or more topical IOP-lowering agents.
Results
No significant difference was found in the overall reduction in IOP after SLT between eyes treated with prostaglandin analogue (PGA) drops alone prior to SLT (7.89 mmHg, n = 74) and eyes that received SLT as first-line treatment (6.88 mmHg, n = 56). Eyes also treated with beta-blockers did show a greater reduction in IOP.
Conclusion
This retrospective study, based in a UK NHS centre, found no significant benefit in using PGA drops prior to SLT compared to SLT as first-line treatment for lowering IOP.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
Data availability
The data that support the findings of this study are not openly available due to reasons of sensitivity and patient confidentiality, but are available from the corresponding author upon reasonable request. Data are in controlled access data storage at Lancashire Teaching Hospitals NHS Trust.
References
https://www.nice.org.uk/guidance/ng811. Overview | Glaucoma: diagnosis and management | Guidance | NICE [Internet]. NICE; 2017 [cited 2025 Feb 14]. Available from: https://www.nice.org.uk/guidance/ng81
Salam A, Butler MK, Davies F, Adam A, Shaikh N. A retrospective review of selective laser trabeculoplasty outcomes at Lancashire Teaching Hospitals, UK. Eye. 2024;38:3357–61.
Hodge WG, Damji KF, Rock W, Buhrmann R, Bovell AM, Pan Y. Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial. Br J Ophthalmol. 2005;89:1157–60.
Bruen R, Lesk MR, Harasymowycz P. Baseline factors predictive of SLT response: a prospective study. J Ophthalmol. 2012;2012:642869.
Latina MA, and De Leon JMS. ‘The effect of topical glaucoma medication on the efficacy of SLT,’ Glaucoma Today, November / December 2004;31–3.
Fahy ET, Montesano G, Garg A, Vickerstaff V, Konstantakopoulou E, Gazzard G. The impact of baseline intraocular pressure on initial treatment response in the light trial: selective laser trabeculoplasty versus medication. Ophthalmology. 2024;131:1366–76.
van der Valk R, Webers CA, Schouten JS, Zeegers MP, Hendrikse F, Prins MH. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis 6of randomized clinical trials. Ophthalmology. 2005;112:1177–85.
Tabet R, Stewart WC, Feldman R, Konstas AGP. A review of additivity to prostaglandin analogs: fixed and unfixed combinations. Surv Ophthalmol. 2008;53:S85–S92.
Jampel HD, Chon BH, Stamper R, et al. Effectiveness of intraocular pressure–lowering medication determined by washout. JAMA Ophthalmol. 2014;132:390–5.
Lim KS, Nau CB, O’Byrne MM, et al. Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study. Ophthalmology. 2008;115:790–5.
Bahler CK, Howell KG, Hann CR, Fautsch MP, Johnson DH. Prostaglandins increase trabecular meshwork outflow facility in cultured human anterior segments. Am J Ophthalmol. 2008;145:114–9.
Alvarado JA, Iguchi R, Juster R, Chen JA, Shifera AS. From the bedside to the bench and back again: predicting and improving the outcomes of SLT glaucoma therapy. Trans Am Ophthalmol Soc. 2009;107:167–81.
Nagar M, Ogunyomade A, O’Brart DP, Howes F, Marshall J. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open-angle glaucoma. Br J Ophthalmol. 2005;89:1413–7.
McIlraith I, Strasfeld M, Colev G, Hutnik CM. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma. 2006;15:124–30.
Khawaja AP, Campbell JH, Kirby N, Chandwani HS, Keyzor I, Parekh M, et al. UK glaucoma real-world data consortium. real-world outcomes of selective laser trabeculoplasty in the United Kingdom. Ophthalmology. 2020;127:748–57.
Woo DM, Healey PR, Graham SL, Goldberg I. Glaucoma laser and medical therapy. Clin Experiment Ophthalmol. 2015;43:320–7.
Nitta K, Sugihara K, Narita A, Naito T, Miki T, Katai M, et al. Efficacy and safety of first-line or second-line selective laser trabeculoplasty for normal-tension glaucoma: a multicentre cohort study. BMJ Open Ophthalmology. 2024;9:e001563.
Yener HI, Ozcimen M. Effectiveness of selective laser trabeculoplasty as initial or adjunctive treatment for primary open-angle glaucoma. Beyoglu Eye J. 2020;5:199–204.
Author information
Authors and Affiliations
Contributions
FD initiated this study, led the literature search, carried out the data collection process and contributed to writing the paper. MKB carried out the statistical analysis and led the writing of the results section. FD and MKB both contributed to editing and agreeing on the final document for submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Davies, F., Butler, M.K. Selective laser trabeculoplasty (SLT) outcomes following topical therapy. Eye (2026). https://doi.org/10.1038/s41433-025-04221-2
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41433-025-04221-2


